Fetal PR Interval in Pregnancies with Intrahepatic Cholestasis of Pregnancy: A Case–Control Study
American Journal of Perinatology · 01.05.2024 · 41 (S 01 S 01) · e2964-e2969
DOI: 10.1055/a-2184-0242 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift American Journal of Perinatology, erschienen am 01.05.2024. Verfasst von Manuel Guerra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Maternal-Fetal Medicine Unit, Department of Obstetrics and Gynecology, Hospital Clínico San José, Santiago, Chile. Hauptthemen laut MEDLINE: Cholestasis, Intrahepatic, Pregnancy Complications, Ursodeoxycholic Acid, Bile Acids and Salts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
Objective
This study had three purposes: first, to explore differences in fetal cardiac function in patients with and without intrahepatic cholestasis of pregnancy (ICP) based on PR interval (the interval between the beginning of the atrial contraction and the beginning of the ventricular contraction). Second, to explore a potential correlation between PR interval and bile acid levels in pregnant women with ICP. Third, to study changes in PR interval of fetuses from pregnant women with ICP after administration of ursodeoxycholic acid (UDCA). Study Design This was a prospective observational case–control study. ICP was defined as palmar plantar pruritus of nocturnal predominance for more than 1 week associated with a total bile acid level >10 μmol/L. Control cases were women with pregnancies scheduled for induction or elective cesarean section at term.
Results
One hundred and ten women with ICP and 72 controls were included in the study. Median gestational age at inclusion was 35.9 weeks. Median PR interval was significantly longer in fetuses of women with ICP (122 vs. 102 ms, p < 0.001). There was a significant correlation between bile acid levels and PR interval (rho = 0.723, p < 0.001). In 22 fetuses, the median PR interval decreased significantly following UDCA administration (134 vs. 118 ms, p = 0.004).
Conclusion
PR interval is longer in fetuses of women with ICP. PR interval was significantly correlated with bile acid levels, and administration of UDCA significantly reduced PR interval. Key Points
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Maternal-Fetal Medicine Unit, Department of Obstetrics and Gynecology, Hospital Clínico San José, Santiago, Chile.
- Department of Perinatology, Clínica Redsalud Vitacura, Santiago, Chile.
- Universitat Autònoma de Barcelona, Bellaterra, Spain.
- Department of Ultrasonography, Clínica Indisa, Santiago, Chile.
- Maternal-Fetal Medicine Unit, Department of Obstetrics and Gynecology, Clínica Alemana, Santiago, Chile.
- Maternal Fetal Medicine Unit, Department of Obstetrics, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.
Zitieren
APA
Guerra, M., Montaño, I., Haye, M. T., Toro, V., & Maiz, N. (2024). Fetal PR Interval in Pregnancies with Intrahepatic Cholestasis of Pregnancy: A Case–Control Study. American Journal of Perinatology, 41(S 01 S 01), e2964-e2969. https://doi.org/10.1055/a-2184-0242
Vancouver
Guerra M, Montaño I, Haye MT, Toro V, Maiz N. Fetal PR Interval in Pregnancies with Intrahepatic Cholestasis of Pregnancy: A Case–Control Study. American Journal of Perinatology. 2024;41(S 01 S 01):e2964-e2969. doi:10.1055/a-2184-0242
BibTeX
@article{Guerra2024,
author = {Guerra, Manuel and Montaño, Ignacio and Haye, María T and Toro, Victoria and Maiz, Nerea},
title = {Fetal PR Interval in Pregnancies with Intrahepatic Cholestasis of Pregnancy: A Case–Control Study},
journal = {American Journal of Perinatology},
year = {2024},
volume = {41},
number = {S 01 S 01},
pages = {e2964--e2969},
doi = {10.1055/a-2184-0242}
}
EUVIMED